• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Artificial Organ Bank Market

    ID: MRFR/HC/28028-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    Artificial Organ Bank Market Research Report By Type (Solid Organs, Soft Tissues, Vascular Grafts), By Application (Transplantation, Research and Development, Education and Training), By Donor Source (Cadaveric, Living, Xenogeneic), By Preservation Method (Static Cold Storage, Dynamic Culturing, Cryopreservation), By End Market (Transplant Centers, Hospitals, Research Institutions, Medical Device Companies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Artificial Organ Bank Market Infographic
    Purchase Options

    Artificial Organ Bank Market Summary

    The Global Artificial Organ Bank Market is projected to experience substantial growth from 15.52 USD Billion in 2024 to 86.10 USD Billion by 2035.

    Key Market Trends & Highlights

    Artificial Organ Bank Key Trends and Highlights

    • The market is expected to grow at a compound annual growth rate (CAGR) of 16.86% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 86.1 USD Billion, indicating a robust expansion.
    • in 2024, the market is valued at 15.52 USD Billion, reflecting the increasing demand for artificial organs.
    • Growing adoption of artificial organs due to advancements in biotechnology is a major market driver.

    Market Size & Forecast

    2024 Market Size 15.52 (USD Billion)
    2035 Market Size 86.10 (USD Billion)
    CAGR (2025-2035) 16.85%

    Major Players

    Organogenesis, Inc., Fresenius Medical Care AG Co. KGaA, Terumo Corporation, Asahi Kasei Corporation, Baxter International Inc., Abbott Laboratories, Medtronic plc, CryoLife, Inc., Stryker Corporation, Braun Melsungen AG, Terumo BCT, Inc., Miromatrix Medical, Inc., Zimmer Biomet Holdings, Inc., Johnson Johnson Services, Inc.

    Artificial Organ Bank Market Trends

    Artificial Organ Bank Market is witnessing substantial growth influenced by advancements in organ preservation techniques to increase organ viability, the rising prevalence of organ failure, and government initiatives to promote organ donation.

    Moreover, increasing investments in research and development, coupled with technological breakthroughs in organ banking, are driving the market forward.

    The Global Artificial Organ Bank Market is poised for transformative growth as advancements in biotechnology and regenerative medicine pave the way for innovative solutions to address organ shortages and enhance patient care.

    U.S. Department of Health and Human Services

    Artificial Organ Bank Market Drivers

    Global Aging Population

    The global aging population is a significant driver of the Global Artificial Organ Bank Market Industry. As life expectancy increases, the incidence of age-related diseases and organ failures rises correspondingly. This demographic shift creates a heightened demand for organ replacements, which artificial organs can fulfill. The World Health Organization has projected that by 2050, the number of people aged 60 years and older will reach 2 billion, further intensifying the need for innovative healthcare solutions. Consequently, the Global Artificial Organ Bank Market Industry is poised for substantial growth as it addresses the challenges posed by an aging population.

    Market Growth Projections

    The Global Artificial Organ Bank Market Industry is projected to experience substantial growth in the coming years. With a market value of 15.5 USD Billion in 2024, it is expected to reach 86.1 USD Billion by 2035, reflecting a remarkable CAGR of 16.86% from 2025 to 2035. This growth trajectory indicates a robust demand for artificial organs, driven by technological advancements, increasing organ transplant needs, and supportive government policies. The market's expansion is indicative of the evolving landscape of healthcare, where artificial organs are becoming integral to addressing organ shortages and improving patient outcomes.

    Rising Awareness and Acceptance

    Rising awareness and acceptance of artificial organs among healthcare professionals and patients are driving the Global Artificial Organ Bank Market Industry. Educational campaigns and successful case studies are contributing to a more informed public perception of artificial organ technologies. As patients become more aware of the options available to them, the acceptance of artificial organs as viable alternatives to traditional transplants is increasing. This shift in perception is crucial for market growth, as it encourages investment and research in artificial organ development. The growing acceptance is expected to significantly influence market dynamics in the coming years.

    Government Initiatives and Funding

    Government initiatives and funding play a pivotal role in the expansion of the Global Artificial Organ Bank Market Industry. Various governments are recognizing the potential of artificial organs to alleviate healthcare burdens and are investing in research and development. For example, funding programs aimed at supporting bioengineering research have been established in several countries, fostering innovation in artificial organ technologies. These initiatives not only enhance the development of new products but also encourage collaboration between public and private sectors. As a result, the market is likely to witness accelerated growth, with projections indicating a CAGR of 16.86% from 2025 to 2035.

    Increasing Organ Transplant Demand

    The demand for organ transplants is escalating globally, significantly influencing the Global Artificial Organ Bank Market Industry. With the increasing prevalence of chronic diseases and organ failures, the need for viable organ replacements is more pressing than ever. According to estimates, the number of patients on waiting lists for organ transplants continues to rise, creating a gap that artificial organs can potentially fill. This growing demand is expected to propel the market to an impressive 86.1 USD Billion by 2035. The urgency for innovative solutions to address organ shortages underscores the critical role of artificial organs in the healthcare landscape.

    Technological Advancements in Bioengineering

    The Global Artificial Organ Bank Market Industry is experiencing rapid growth due to advancements in bioengineering technologies. Innovations such as 3D bioprinting and tissue engineering are enabling the creation of artificial organs that closely mimic the functionality of natural organs. For instance, researchers are developing bioengineered hearts and kidneys that have shown promising results in preclinical trials. These advancements not only enhance the feasibility of artificial organs but also contribute to the overall market growth, projected to reach 15.5 USD Billion in 2024. As these technologies continue to evolve, they are likely to drive further investment and interest in the Global Artificial Organ Bank Market Industry.

    Market Segment Insights

    Artificial Organ Bank Market Type Insights

    The Artificial Organ Bank Market segmentation by Type covers Solid Organs, Soft Tissues, and Vascular Grafts. Solid Organs, such as kidneys, hearts, and livers, account for a significant share of the market due to the high prevalence of organ failure and the increasing demand for organ transplants.

    The scarcity of donor organs and the long waiting lists for transplantation drive the growth of the solid organ bank segment. Soft Tissues, including skin, tendons, and ligaments, are used in various surgical procedures such as wound repair, reconstructive surgeries, and dental implants.

    The rising demand for cosmetic and reconstructive surgeries contributes to the growth of the soft tissue bank segment. Vascular Grafts, used to replace damaged or diseased blood vessels, represent a growing segment of the market.

    The increasing prevalence of cardiovascular diseases and the aging population fuel the demand for vascular grafts. The growth is attributed to factors such as the increasing incidence of chronic diseases, the rising demand for organ transplantation, and technological advancements in organ preservation and transplantation techniques.

    Artificial Organ Bank Market Application Insights

    The application segment plays a crucial role in shaping the  Artificial Organ Bank Market revenue. Transplantation remains the primary driver, accounting for a significant share of the market. In 2023, the Transplantation segment was valued at approximately 7.29 billion USD and is projected to grow exponentially in the coming years.

    Research and Development is another key application, with a market size of around 2.84 billion USD in 2023 and is poised for substantial growth. Additionally, Education and Training are gaining traction, with an estimated market value of 1.24 billion USD in 2023.

    This segment is expected to witness significant growth due to rising awareness and advancements in artificial organ technology. Overall, the  Artificial Organ Bank Market segmentation provides insights into the diverse applications and their contributions to the overall market growth.

    Artificial Organ Bank Market Donor Source Insights

    The Artificial Organ Bank Market is segmented based on donor sources into cadaveric, living, and xenogeneic. Cadaveric organs are harvested from deceased donors while living organs are donated by living donors. Xenogeneic organs are harvested from animals and transplanted into humans.

    The cadaveric donor source segment held the largest market share in 2023 and is expected to continue to dominate the market over the forecast period. This is due to the increasing number of organ donations from deceased donors. The living donor source segment is expected to grow at a faster rate than the cadaveric donor source segment over the forecast period.

    This is due to the increasing awareness of the importance of organ donation and the growing number of living donors. The xenogeneic donor source segment is expected to grow at a slower rate than the cadaveric and living donor source segments over the forecast period.

    This is due to the ethical concerns associated with xenotransplantation and the technical challenges involved in transplanting animal organs into humans.

    Overall, the Artificial Organ Bank Market is expected to grow at a significant rate over the forecast period. This is due to the increasing demand for organ transplants, the growing number of organ donations, and the technological advancements in organ transplantation.

    Artificial Organ Bank Market Preservation Method Insights

    The Artificial Organ Bank Market is segmented based on the Preservation Method into Static Cold Storage, Dynamic Culturing, and Cryopreservation. The Static Cold Storage segment held the largest market share in 2023 and is expected to continue its dominance throughout the forecast period.

    The growth of this segment can be attributed to the simplicity and cost-effectiveness of the technique. Dynamic Culturing is expected to witness significant growth during the forecast period due to its ability to maintain organ viability for an extended period.

    Cryopreservation is a promising segment that is expected to gain traction in the future due to its potential to preserve organs for long-term storage.

    Artificial Organ Bank Market End Market Insights

    The End Market segment of the  Artificial Organ Bank Market is comprised of transplant centers, hospitals, research institutions, and medical device companies. Transplant centers account for the largest share of the market due to the high demand for organ transplants. Hospitals are also a major end market, as they provide pre-and post-operative care for transplant patients.

    Research institutions are involved in the development of new artificial organs and technologies, and medical device companies manufacture and supply artificial organs and related products.

    The Artificial Organ Bank Market is expected to grow significantly in the coming years, driven by the increasing prevalence of end-stage organ failure, the rising demand for organ transplants, and the growing number of research and development activities in the field.

    Get more detailed insights about Artificial Organ Bank Market Research Report — Global Forecast till 2034

    Regional Insights

    The Artificial Organ Bank Market is segmented into North America, Europe, APAC, South America, and MEA. Among these regions, North America held the largest market share in 2023, owing to the presence of a large number of organ transplant centers and a high prevalence of chronic diseases.

    Europe is expected to be the second largest market, followed by APAC. The APAC region is expected to witness the highest growth rate during the forecast period due to the increasing demand for organ transplantation and the growing awareness about organ donation. South America and MEA are expected to account for a smaller share of the  market.

    Key Players and Competitive Insights

    Major players in the Artificial Organ Bank Market are emphasizing consolidating their position. The Artificial Organ Bank Market industry is in a developmental phase due to several recent innovations in the industry.

    Leading Artificial Organ Bank Market players are implementing advanced technologies in their offerings to enhance their overall Artificial Organ Bank Market development. Artificial Organ Bank Market competitive landscape ly is competitive in nature, and the industry is highly fragmented.

    Organogenesis, which is a leading Artificial Organ Bank Market player, is a biotechnology company that specializes in developing and commercializing regenerative medicine technologies. The company's mission is to provide patients with lifesaving and life-enhancing treatments.

    Organogenesis has a strong track record of innovation and has developed a number of novel products, including Apligraf, a living skin equivalent used to treat burns and other wounds, and Dermagraft, a living dermal substitute used to treat diabetic foot ulcers.

    A competitor of Organogenesis is MiMedx Group, which is also a leading Artificial Organ Bank Market player. MiMedx Group is a regenerative medicine company that develops, manufactures, and markets proprietary regenerative biomaterial products and bioimplants.

    The company's products are used in a variety of surgical procedures, including orthopedics, cardiovascular, and wound care. MiMedx Group has a strong distribution network, and its products are sold in over 40 countries worldwide.

    Key Companies in the Artificial Organ Bank Market market include

    Industry Developments

    The growth can be attributed to increasing organ failure rates, rising prevalence of chronic diseases, and advancements in organ preservation techniques. Key market players are focusing on developing innovative technologies to improve organ viability and expand organ donor pools.

    Recent developments include the use of 3D bioprinting for organ fabrication and the establishment of organ exchange platforms to facilitate organ sharing.

    Future Outlook

    Artificial Organ Bank Market Future Outlook

    The Artificial Organ Bank Market is projected to grow at a 16.85% CAGR from 2025 to 2035, driven by technological advancements, increasing organ transplant demand, and regulatory support.

    New opportunities lie in:

    • Develop personalized artificial organs using 3D bioprinting technology.
    • Expand telemedicine services for remote organ monitoring and management.
    • Invest in partnerships with biotech firms for innovative organ preservation solutions.

    By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in organ replacement solutions.

    Market Segmentation

    Artificial Organ Bank Market Type Outlook

    • Solid Organs Soft Tissues Vascular Grafts
    • Solid Organs
    • Soft Tissues
    • Vascular Grafts

    Artificial Organ Bank Market End Market Outlook

    • Transplant Centers Hospitals Research Institutions Medical Device Companies
    • Transplant Centers
    • Hospitals
    • Research Institutions
    • Medical Device Companies

    Artificial Organ Bank Market Application Outlook

    • Transplantation Research and Development Education and Training
    • Transplantation
    • Research and Development
    • Education and Training

    Artificial Organ Bank Market Donor Source Outlook

    • Cadaveric Living Xenogeneic
    • Cadaveric
    • Living
    • Xenogeneic

    Artificial Organ Bank Market Preservation Method Outlook

    • Static Cold Storage Dynamic Culturing Cryopreservation
    • Static Cold Storage
    • Dynamic Culturing
    • Cryopreservation

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024   15.52 (USD Billion)
    Market Size 2025   18.14 (USD Billion)
    Market Size 2035 86.10 (USD Billion)
    Compound Annual Growth Rate (CAGR) 16.85% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2020 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled Organogenesis, Inc., Fresenius Medical Care AG Co. KGaA, Terumo Corporation, Asahi Kasei Corporation, Baxter International Inc., Abbott Laboratories, Medtronic plc, CryoLife, Inc., Stryker Corporation, B. Braun Melsungen AG, Terumo BCT, Inc., Miromatrix Medical, Inc., Zimmer Biomet Holdings, Inc., Johnson Johnson Services, Inc.
    Segments Covered Type, Application, Donor Source, Preservation Method, End Market, Regional
    Key Market Opportunities Aging population Advancements in technology Increasing research and development activities Rising demand for organ transplants Government initiatives
    Key Market Dynamics Rising demand for organ transplants Technological advancements Government initiatives Increasing prevalence of chronic diseases Growing investment in research and development
    Countries Covered North America, Europe, APAC, South America, MEA

    FAQs

    What is the projected growth of the Artificial Organ Bank market?

    The Artificial Organ Bank market is the expected increase in total market value of 86.1 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

    What is the size of the Artificial Organ Bank market?

    Artificial Organ Bank market size was valued at approximately 15.52 billion USD in 2024. This figure will reach 86.1 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

    What is the CAGR of the Artificial Organ Bank market?

    Artificial Organ Bank market is expected to grow at a CAGR of 16.85% between 2025 and 2035.

    How much will the Artificial Organ Bank market be worth by 2035?

    Artificial Organ Bank market is expected to be worth of 86.1 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

    How will the Artificial Organ Bank market perform over the next 10 years?

    Over the next 10 years the Artificial Organ Bank market is expected to shift from usd billion 15.52 to 86.1 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

    What are the key regions driving the growth of the market?

    North America is expected to hold the largest market share, while Asia Pacific is projected to witness the highest growth rate during the forecast period.

    Which applications are expected to contribute significantly to market growth?

    Organ transplantation and research and development are anticipated to be the major application areas, driving market expansion.

    What are the major factors influencing market growth?

    Increasing demand for organ transplantation, technological advancements, and government support are the key factors driving market growth.

    What are the key trends shaping the market?

    Personalized medicine, 3D bioprinting, and regenerative medicine are emerging trends shaping the market.

    What is the outlook for the market?

    The market is expected to experience steady growth, driven by increasing healthcare spending and technological advancements.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials